At a glance
ClinicalIndex Comparison RecordN/ACompleted· 151 enrolled
Drug / intervention
PregSense™ +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Study Evaluating the Safety of PregSense and Comparative Performance of PregSense Versus CTG in Prenatal Monitoring of Pregnant Subjects
In Brief
A clinical study evaluating PregSense™ and Cardiotocopraphy (CTG) for Pregnancy. Completed, enrolled 151 participants across 4 sites in 3 countries.
Detailed Summary
This clinical study will evaluate the safety of PregSense™ and Comparative Performance of PregSense™ versus CTG in Prenatal Monitoring of Pregnant subjects.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPregnancy
CountriesGermany, Israel, United States
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
Enrollment StartMar 2018
First PostedApr 2018
Primary CompletionJun 2018
Study CompletionNov 2018
TodayJul 2026
First PostedApr 20, 2018
Enrollment StartMar 1, 2018
Primary CompletionJun 27, 2018
Study CompletionNov 8, 2018
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 8.2 years ago
Interventions
PregSense™device
PregSense™ wearable device will be applied for maternal-fetal monitoring
Cardiotocopraphy (CTG)device
Cardiotocopraphy (CTG) will be applied for maternal-fetal monitoring